Identification of New Loci Involved in the Host
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
In-Depth Analysis of Genetic Variation Associated with Severe West Nile Viral Disease
Article In-Depth Analysis of Genetic Variation Associated with Severe West Nile Viral Disease Megan E. Cahill 1, Mark Loeb 2, Andrew T. Dewan 1 and Ruth R. Montgomery 3,* 1 Center for Perinatal, Pediatric and Environmental Epidemiology, Department of Chronic Disease Epidemiology, Yale School of Public Health, 1 Church Street, New Haven, CT 06510, USA; [email protected] (M.E.C.); [email protected] (A.T.D.) 2 3208 Michael DeGroote Centre for Learning & Discovery, Division of Clinical Pathology, McMaster University, Hamilton, ON L8S 4L8, Canada; [email protected] 3 Department of Internal Medicine, Yale School of Medicine, 300 Cedar Street, New Haven, CT 06520, USA * Correspondence: [email protected] Received: 30 October 2020; Accepted: 3 December 2020; Published: 8 December 2020 Abstract: West Nile virus (WNV) is a mosquito-borne virus which causes symptomatic disease in a minority of infected humans. To identify novel genetic variants associated with severe disease, we utilized data from an existing case-control study of WNV and included population controls for an expanded analysis. We conducted imputation and gene-gene interaction analysis in the largest and most comprehensive genetic study conducted to date for West Nile neuroinvasive disease (WNND). Within the imputed West Nile virus dataset (severe cases n = 381 and asymptomatic/mild controls = 441), we found novel loci within the MCF.2 Cell Line Derived Transforming Sequence Like (MCF2L) gene (rs9549655 and rs2297192) through the individual loci analyses, although none reached statistical significance. Incorporating population controls from the Wisconsin Longitudinal Study on Aging (n = 9012) did not identify additional novel variants, a possible reflection of the cohort’s inclusion of individuals who could develop mild or severe WNV disease upon infection. -
A Rare Variant in MCF2L Identified Using Exclusion Linkage in A
European Journal of Human Genetics (2016) 24, 86–91 & 2016 Macmillan Publishers Limited All rights reserved 1018-4813/16 www.nature.com/ejhg ARTICLE A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis Stephanie Maiwald1,7, Mahdi M Motazacker1,7,8, Julian C van Capelleveen1, Suthesh Sivapalaratnam1, Allard C van der Wal2, Chris van der Loos2, John JP Kastelein1, Willem H Ouwehand3,4, G Kees Hovingh1, Mieke D Trip1,5, Jaap D van Buul6 and Geesje M Dallinga-Thie*,1 Cardiovascular disease (CVD) is a major cause of death in Western societies. CVD risk is largely genetically determined. The molecular pathology is, however, not elucidated in a large number of families suffering from CVD. We applied exclusion linkage analysis and next-generation sequencing to elucidate the molecular defect underlying premature CVD in a small pedigree, comprising two generations of which six members suffered from premature CVD. A total of three variants showed co-segregation with the disease status in the family. Two of these variants were excluded from further analysis based on the prevalence in replication cohorts, whereas a non-synonymous variant in MCF.2 Cell Line Derived Transforming Sequence-like protein (MCF2L, c.2066A4G; p.(Asp689Gly); NM_001112732.1), located in the DH domain, was only present in the studied family. MCF2L is a guanine exchange factor that potentially links pathways that signal through Rac1 and RhoA. Indeed, in HeLa cells, MCF2L689Gly failed to activate Rac1 as well as RhoA, resulting in impaired stress fiber formation. Moreover, MCF2L protein was found in human atherosclerotic lesions but not in healthy tissue segments. -
Transcription-Replication Collisions—A Series of Unfortunate Events
biomolecules Review Transcription-Replication Collisions—A Series of Unfortunate Events Commodore St Germain 1,2,*, Hongchang Zhao 2 and Jacqueline H. Barlow 2,* 1 School of Mathematics and Science, Solano Community College, 4000 Suisun Valley Road, Fairfield, CA 94534, USA 2 Department of Microbiology and Molecular Genetics, University of California Davis, One Shields Avenue, Davis, CA 95616, USA; [email protected] * Correspondence: [email protected] (C.S.G.); [email protected] (J.H.B.) Abstract: Transcription-replication interactions occur when DNA replication encounters genomic regions undergoing transcription. Both replication and transcription are essential for life and use the same DNA template making conflicts unavoidable. R-loops, DNA supercoiling, DNA secondary structure, and chromatin-binding proteins are all potential obstacles for processive replication or transcription and pose an even more potent threat to genome integrity when these processes co-occur. It is critical to maintaining high fidelity and processivity of transcription and replication while navigating through a complex chromatin environment, highlighting the importance of defining cellular pathways regulating transcription-replication interaction formation, evasion, and resolution. Here we discuss how transcription influences replication fork stability, and the safeguards that have evolved to navigate transcription-replication interactions and maintain genome integrity in mammalian cells. Keywords: DNA replication; transcription; R-loops; replication stress Citation: St Germain, C.; Zhao, H.; Barlow, J.H. Transcription-Replication Collisions—A Series of Unfortunate Events. Biomolecules 2021, 11, 1249. 1. Introduction https://doi.org/10.3390/ From bacteria to humans, transcription has been identified as a source of genome biom11081249 instability, initially observed as spontaneous recombination referred to as transcription- associated recombination (TAR) [1]. -
Nucleoporin TPR Is an Integral Component of the TREX-2 Mrna Export Pathway
ARTICLE https://doi.org/10.1038/s41467-020-18266-2 OPEN Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway Vasilisa Aksenova1, Alexandra Smith1, Hangnoh Lee1, Prasanna Bhat 2, Caroline Esnault3, Shane Chen1, James Iben4, Ross Kaufhold1, Ka Chun Yau 1, Carlos Echeverria1, Beatriz Fontoura 2, Alexei Arnaoutov1 & ✉ Mary Dasso 1 Nuclear pore complexes (NPCs) are important for cellular functions beyond nucleocyto- 1234567890():,; plasmic trafficking, including genome organization and gene expression. This multi-faceted nature and the slow turnover of NPC components complicates investigations of how indi- vidual nucleoporins act in these diverse processes. To address this question, we apply an Auxin-Induced Degron (AID) system to distinguish roles of basket nucleoporins NUP153, NUP50 and TPR. Acute depletion of TPR causes rapid and pronounced changes in tran- scriptomic profiles. These changes are dissimilar to shifts observed after loss of NUP153 or NUP50, but closely related to changes caused by depletion of mRNA export receptor NXF1 or the GANP subunit of the TRanscription-EXport-2 (TREX-2) mRNA export complex. More- over, TPR depletion disrupts association of TREX-2 subunits (GANP, PCID2, ENY2) to NPCs and results in abnormal RNA transcription and export. Our findings demonstrate a unique and pivotal role of TPR in gene expression through TREX-2- and/or NXF1-dependent mRNA turnover. 1 Division of Molecular and Cellular Biology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. 2 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. 3 Bioinformatics and Scientific Programming Core, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20879, USA. -
HHS Public Access Author Manuscript
HHS Public Access Author manuscript Author Manuscript Author ManuscriptGenet Epidemiol Author Manuscript. Author Author Manuscript manuscript; available in PMC 2016 June 01. Published in final edited form as: Genet Epidemiol. 2015 December ; 39(8): 664–677. doi:10.1002/gepi.21932. Multiple SNP-sets Analysis for Genome-wide Association Studies through Bayesian Latent Variable Selection Zhaohua Lu, Hongtu Zhu, Rebecca C Knickmeyer, Patrick F. Sullivan, Williams N. Stephanie, and Fei Zou for the Alzheimer’s Disease Neuroimaging Initiative* Departments of Biostatistics, Psychiatry, and Genetics and Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA Abstract The power of genome-wide association studies (GWAS) for mapping complex traits with single SNP analysis may be undermined by modest SNP effect sizes, unobserved causal SNPs, correlation among adjacent SNPs, and SNP-SNP interactions. Alternative approaches for testing the association between a single SNP-set and individual phenotypes have been shown to be promising for improving the power of GWAS. We propose a Bayesian latent variable selection (BLVS) method to simultaneously model the joint association mapping between a large number of SNP-sets and complex traits. Compared to single SNP-set analysis, such joint association mapping not only accounts for the correlation among SNP-sets, but also is capable of detecting causal SNP- sets that are marginally uncorrelated with traits. The spike-slab prior assigned to the effects of SNP-sets can greatly reduce the dimension of effective SNP-sets, while speeding up computation. An efficient MCMC algorithm is developed. Simulations demonstrate that BLVS outperforms several competing variable selection methods in some important scenarios. -
Bioinformatics Tools for the Analysis of Gene-Phenotype Relationships Coupled with a Next Generation Chip-Sequencing Data Processing Pipeline
Bioinformatics Tools for the Analysis of Gene-Phenotype Relationships Coupled with a Next Generation ChIP-Sequencing Data Processing Pipeline Erinija Pranckeviciene Thesis submitted to the Faculty of Graduate and Postdoctoral Studies in partial fulfillment of the requirements for the Doctorate in Philosophy degree in Cellular and Molecular Medicine Department of Cellular and Molecular Medicine Faculty of Medicine University of Ottawa c Erinija Pranckeviciene, Ottawa, Canada, 2015 Abstract The rapidly advancing high-throughput and next generation sequencing technologies facilitate deeper insights into the molecular mechanisms underlying the expression of phenotypes in living organisms. Experimental data and scientific publications following this technological advance- ment have rapidly accumulated in public databases. Meaningful analysis of currently avail- able data in genomic databases requires sophisticated computational tools and algorithms, and presents considerable challenges to molecular biologists without specialized training in bioinfor- matics. To study their phenotype of interest molecular biologists must prioritize large lists of poorly characterized genes generated in high-throughput experiments. To date, prioritization tools have primarily been designed to work with phenotypes of human diseases as defined by the genes known to be associated with those diseases. There is therefore a need for more prioritiza- tion tools for phenotypes which are not related with diseases generally or diseases with which no genes have yet been associated in particular. Chromatin immunoprecipitation followed by next generation sequencing (ChIP-Seq) is a method of choice to study the gene regulation processes responsible for the expression of cellular phenotypes. Among publicly available computational pipelines for the processing of ChIP-Seq data, there is a lack of tools for the downstream analysis of composite motifs and preferred binding distances of the DNA binding proteins. -
DNA Methylation Analysis on Purified Neurons and Glia Dissects Age And
Gasparoni et al. Epigenetics & Chromatin (2018) 11:41 https://doi.org/10.1186/s13072-018-0211-3 Epigenetics & Chromatin RESEARCH Open Access DNA methylation analysis on purifed neurons and glia dissects age and Alzheimer’s disease‑specifc changes in the human cortex Gilles Gasparoni1 , Sebastian Bultmann2, Pavlo Lutsik3, Theo F. J. Kraus4, Sabrina Sordon5, Julia Vlcek4, Vanessa Dietinger4, Martina Steinmaurer4, Melanie Haider4, Christopher B. Mulholland2, Thomas Arzberger4, Sigrun Roeber4, Matthias Riemenschneider5, Hans A. Kretzschmar4, Armin Giese4, Heinrich Leonhardt2 and Jörn Walter1* Abstract Background: Epigenome-wide association studies (EWAS) based on human brain samples allow a deep and direct understanding of epigenetic dysregulation in Alzheimer’s disease (AD). However, strong variation of cell-type propor- tions across brain tissue samples represents a signifcant source of data noise. Here, we report the frst EWAS based on sorted neuronal and non-neuronal (mostly glia) nuclei from postmortem human brain tissues. Results: We show that cell sorting strongly enhances the robust detection of disease-related DNA methylation changes even in a relatively small cohort. We identify numerous genes with cell-type-specifc methylation signatures and document diferential methylation dynamics associated with aging specifcally in neurons such as CLU, SYNJ2 and NCOR2 or in glia RAI1,CXXC5 and INPP5A. Further, we found neuron or glia-specifc associations with AD Braak stage progression at genes such as MCF2L, ANK1, MAP2, LRRC8B, STK32C and S100B. A comparison of our study with previous tissue-based EWAS validates multiple AD-associated DNA methylation signals and additionally specifes their origin to neuron, e.g., HOXA3 or glia (ANK1). In a meta-analysis, we reveal two novel previously unrecognized methylation changes at the key AD risk genes APP and ADAM17. -
Advances in Osteoarthritis Genetics Kalliope Panoutsopoulou, Eleftheria Zeggini
Review J Med Genet: first published as 10.1136/jmedgenet-2013-101754 on 18 July 2013. Downloaded from Advances in osteoarthritis genetics Kalliope Panoutsopoulou, Eleftheria Zeggini Department of Human ABSTRACT the rise. In the USA alone 27 million adults had Genetics, Wellcome Trust Osteoarthritis (OA), the most common form of arthritis, clinical evidence of OA in 2005, a rise of nearly Sanger Institute, 67 Cambridgeshire, UK is a highly debilitating disease of the joints and can lead 30% from the estimate of 21 million in 1995. to severe pain and disability. There is no cure for OA. With longer life expectancies and the obesity pan- Correspondence to Current treatments often fail to alleviate its symptoms demic—with age and obesity/overweight being well Dr Eleftheria Zeggini and leading to an increased demand for joint replacement established risk factors for disease development and Dr Kalliope Panoutsopoulou, surgery. Previous epidemiological and genetic research progression—the prevalence of OA is expected to Wellcome Trust Sanger Institute, Hinxton, The Morgan has established that OA is a multifactorial disease with increase continuously and sharply. Building, Wellcome Trust both environmental and genetic components. Over the Although the aetiology of OA is not fully under- Genome Campus, Hinxton, past 6 years, a candidate gene study and several stood it has been well established that the disease is Cambridgeshire, genome-wide association scans (GWAS) in populations caused by complex interplay between environmen- CB10 1HH, UK; [email protected] and of Asian and European descent have collectively tal and genetic factors. Age is the strongest risk [email protected] established 15 loci associated with knee or hip OA that factor for all types of OA whereas obesity appears have been replicated with genome-wide significance, to confer the greatest risk in knee OA, particularly Received 16 April 2013 shedding some light on the aetiogenesis of the disease. -
A Rare Variant in MCF2L Identified Using Exclusion Linkage in a Pedigree with Premature Atherosclerosis
UvA-DARE (Digital Academic Repository) Rare genetic variants associated with early onset CVD Maiwald, S. Publication date 2015 Document Version Final published version Link to publication Citation for published version (APA): Maiwald, S. (2015). Rare genetic variants associated with early onset CVD. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:10 Oct 2021 Chapter 7 Chapter 8 A Rare Variant in MCF2L Identified using Exclusion Linkage in a Pedigree with Premature Atherosclerosis S. Maiwald, M. M. Motazacker, J. C. van Capelleveen, S. Sivapalaratnam, A. C. van der Wal, C. van der Loos, J. J. P. Kastelein, W. H. Ouwehand, G. K. Hovingh, M. D. Trip, J. D. van Buul, G. M. Dallinga-Thie Submitted A Rare Variant in MCF2L Identified using Exclusion Linkage in a Pedigree with PAS Abstract Background Cardiovascular disease (CVD) is a major cause of worldwide death. -
Robles JTO Supplemental Digital Content 1
Supplementary Materials An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers Ana I. Robles1, Eri Arai2, Ewy A. Mathé1, Hirokazu Okayama1, Aaron Schetter1, Derek Brown1, David Petersen3, Elise D. Bowman1, Rintaro Noro1, Judith A. Welsh1, Daniel C. Edelman3, Holly S. Stevenson3, Yonghong Wang3, Naoto Tsuchiya4, Takashi Kohno4, Vidar Skaug5, Steen Mollerup5, Aage Haugen5, Paul S. Meltzer3, Jun Yokota6, Yae Kanai2 and Curtis C. Harris1 Affiliations: 1Laboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 2Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 3Genetics Branch, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 4Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 5Department of Chemical and Biological Working Environment, National Institute of Occupational Health, NO-0033 Oslo, Norway. 6Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), 08916 Badalona (Barcelona), Spain. List of Supplementary Materials Supplementary Materials and Methods Fig. S1. Hierarchical clustering of based on CpG sites differentially-methylated in Stage I ADC compared to non-tumor adjacent tissues. Fig. S2. Confirmatory pyrosequencing analysis of DNA methylation at the HOXA9 locus in Stage I ADC from a subset of the NCI microarray cohort. 1 Fig. S3. Methylation Beta-values for HOXA9 probe cg26521404 in Stage I ADC samples from Japan. Fig. S4. Kaplan-Meier analysis of HOXA9 promoter methylation in a published cohort of Stage I lung ADC (J Clin Oncol 2013;31(32):4140-7). Fig. S5. Kaplan-Meier analysis of a combined prognostic biomarker in Stage I lung ADC. -
Indoxyl Sulfate and P-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance
BASIC RESEARCH www.jasn.org Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance Britt Opdebeeck ,1 Stuart Maudsley,2,3 Abdelkrim Azmi,3 Annelies De Maré,1 Wout De Leger,4 Bjorn Meijers,5,6 Anja Verhulst,1 Pieter Evenepoel,5,6 Patrick C. D’Haese,1 and Ellen Neven1 1Laboratory of Pathophysiology, Department of Biomedical Sciences, 2Receptor Biology Lab, Department of Biomedical Sciences, and 3Translational Neurobiology Group, Flanders Institute of Biotechnology Center for Molecular Neurology, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; 4Division of Molecular Design and Synthesis, Department of Chemistry and 6Laboratory of Nephrology, Department of Immunology and Microbiology, Catholic University of Leuven, Leuven, Belgium; and 5Division of Internal Medicine, Nephrology, University Hospitals Leuven, Leuven, Belgium ABSTRACT Background Protein-bound uremic toxins indoxyl sulfate (IS) and p-cresyl sulfate (PCS) have been associ- ated with cardiovascular morbidity and mortality in patients with CKD. However, direct evidence for a role of these toxins in CKD-related vascular calcification has not been reported. Methods To study early and late vascular alterations by toxin exposure, we exposed CKD rats to vehicle, IS (150 mg/kg per day), or PCS (150 mg/kg per day) for either 4 days (short-term exposure) or 7 weeks (long-term exposure). We also performed unbiased proteomic analyses of arterial samples coupled to functional bioinformatic annotation analyses to investigate molecular signaling events associated with toxin-mediated arterial calcification. Results Long-term exposure to either toxin at serum levels similar to those experienced by patients with CKD significantly increased calcification in the aorta and peripheral arteries. -
Rabbit Anti-ENY2 Antibody-SL14605R
SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-ENY2 antibody SL14605R Product Name: ENY2 Chinese Name: ENY2蛋白抗体 1810057B09Rik; 6720481I12; DC6; e(y)2; Enhancer of yellow 2 transcription factor Alias: homolog; eny2; ENY2_HUMAN; Ey2. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep,Rhesus monkey ELISA=1:500-1000IHC-P=1:400-800IHC-F=1:400-800ICC=1:100-500IF=1:100- 500(Paraffin sections need antigen repair) Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 12kDa Cellular localization: The nucleus Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human ENY2:51-101/101 Lsotype: IgGwww.sunlongbiotech.com Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. PubMed: PubMed Made up of nearly 146 million bases, chromosome 8 encodes about 800 genes. Translocation of portions of chromosome 8 with amplifications of the c-Myc gene are found in some leukemias and lymphomas, and typically associated with a poor Product Detail: prognosis.